Summary
CVS Health Corporation (then CVS Caremark Corporation) announced on December 10, 2013, a significant strategic partnership with Cardinal Health, Inc. to form a new, equally-owned joint venture focused on generic pharmaceutical sourcing. This entity aims to leverage the combined expertise of both companies to negotiate and secure generic drug supply contracts, expected to be operational by July 1, 2014, with an initial 10-year term. This venture represents a strategic move to enhance cost-efficiency and supply chain strength in the critical area of generic pharmaceuticals. Investors should note that the agreement includes a quarterly payment of $25 million from Cardinal Health to CVS Caremark over the life of the agreement, and no physical assets are being transferred, indicating a focus on operational and contractual synergies rather than asset consolidation.
Key Highlights
- 1Formation of a 50/50 joint venture with Cardinal Health, Inc. for generic pharmaceutical sourcing.
- 2The joint venture is expected to be operational by July 1, 2014, with a 10-year initial term.
- 3The entity will consolidate sourcing and supply chain expertise for generic pharmaceuticals from both CVS Caremark and Cardinal Health.
- 4Cardinal Health will make quarterly payments of $25 million to CVS Caremark over the life of the agreement.
- 5No physical assets are being contributed by either company to the joint venture.
- 6Minimal funding is required to capitalize the new entity.
- 7The agreement is subject to customary closing conditions and final documentation.